You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
STEER PATIENT CLEAR
OF INAPPROPRIATE AND
UNNECESSARY SHOCKS WITH
Defibrillators save lives but shocks can lead to patient pain and anxiety decreasing quality of life resulting in increased costs and resource usage of the healthcare system.
20 years ago, Medtronic decided to start a quest with the goal to ONLY SHOCK TO SAVE A LIFE.
Inappropriate shock rate in dual chamber and triple chamber ICD patients at one year.1
Inappropriate shock rate in single chamber ICD patients at one year.1
Further reduced shocks while using ATP during charging, along with 30/40 Long Detection Interval (LDI).2
2019 HRS/EHRA/APHRS/LAHRS EXPERT CONSENSUS PROGRAMMING GUIDELINES3
In contrast, the recommendations differed from other manufacturers’ nominal settings.
NOMINALS MAKE AN IMPACT
of devices programmed according to consensus document.20
of ICDs programmed according to guidelines in Medtronic devices.20
Medtronic patients received significantly fewer ICD therapy compared to other device patients.20
ICDS & CRT-DS
Please visit our Medtronic website for more information on our ICD/CRT-D portfolio.
1. Auricchio A et al. Heart Rhythm 2015;12:926-936.
2. Arenal A et al. Europace 2016;18:1719–1725.
3. Stiles MK et al. Europace 2019;21:1442–1443.
4. Wilkoff BL et al. Circulation 2001;103(3):381-386.
5. Wathen MS et al. Circulation 2001;104:796-801.
6. Wathen MS et al. Circulation 2004;110;2591-2596
7. Klein GJ et al. J Cardiovasc Electrophysiol 2006;17:1310-1319.
8. Wilkoff BL et al. J Am Coll Cardiol 2006;48:330 –339.
9. Schoels W et al. Heart Rhythm 2007;4:879–885.
10. Wilkoff BL et al. J Am Coll Cardiol 2008;52:541–50.
11. Gasparini M et al. European Heart Journal (2009) 30, 2758–2767
12. Toquero J et al. Europace (2009) 11, 727–733
13. Gasparini M et al. Am Heart J 2010;159:1116-1123.
14. Santini M et al. J Interv Card Electrophysiol (2010) 27:127–135
15. Volosin KJ et al. J Cardiovasc Electrophysiol 2011;22:280–289.
16. Gasparini M et al. JAMA. 2013;309(18):1903-1911.
17. Silver MT et al. Heart Rhythm 2015;12:545-53.
18. Regoli F et al. BMC Cardiovascular Disorders (2019) 19:146
19. Cheng A et al. J Cardiovasc Electrophysiology. 2019;30(12):2877-2884.
20. Ananwattanasuk T, et al. Heart Rhythm 2020, advance access published Feb 2020
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu
* only 2 changes with CobaltTM & CromeTM devices.
One additional recommendation on CRTD’s: Adaptive BiV or LV for pts with intact AV conduction and LBBB (nominally on in Medtronic CRT devices).